Journal of Hepatocellular Carcinoma
Volume 10, 2023 - Issue
Open access
134
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway
Yanjun Gao1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;2 Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People’s Republic of China
https://orcid.org/0000-0003-3198-4930View further author information
Yingge Li1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;2 Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People’s Republic of ChinaView further author information
, Zheming Liu1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;2 Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People’s Republic of ChinaView further author information
, Yi Dong1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;2 Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People’s Republic of ChinaView further author information
, Siqi Yang1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;2 Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People’s Republic of ChinaView further author information
, Bin Wu1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;3 Department of Oncology, Huang-Gang Central Hospital, Huanggang, 438000, People’s Republic of ChinaView further author information
, Mengxia Xiao1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;4 Department of Oncology, Yichun People’s Hospital, Yichun, 336000, People’s Republic of ChinaView further author information
, Chen Chen5 Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of ChinaView further author information
, Yingmei Wen1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;2 Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People’s Republic of ChinaView further author information
, Lei Chen1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of ChinaView further author information
, Haijuan Jiang6 Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People’s Republic of ChinaView further author information
& Yi Yao1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China;2 Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-3110-1720View further author information
Pages 2021-2036
|
Received 08 Feb 2023, Accepted 24 Oct 2023, Published online: 07 Nov 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.